Donor CD8 cells prevent allogeneic marrow graft rejection in mice: Potential implications for marrow transplantation in humans

Journal of Experimental Medicine

Volumn 178, Issue 2, 1993, Pages 703-712

  Martin, Paul J ^a,b  

^a FRED HUTCHINSON CANCER RESEARCH CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; ARTICLE; CELL MATURATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; IMMUNOCOMPETENCE; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANIMAL; ANTIGENS, CD8; BONE MARROW TRANSPLANTATION; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; GRAFT REJECTION; HUMAN; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS; WHOLE-BODY IRRADIATION;

EID: 0027294049     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.178.2.703     Document Type: Article

References (49)

1. Komgold, R., and J. Sprent. 1987. T cell subsets and graft-versus-host disease. Transplantation (Baltimore). 44:335.
2. Martin, P.J., and N. Keman. 1990. T cell depletion for GVHD prevention in humans. In Graft Versus Host Disease: Research and Clinical Management. S. Burakoff, H.J. Deeg, J. Ferrara, and K. Atkinson, editors. Marcel Dekker, Inc., New York, NY. 371-387.
3. Martin, P.J., J.A. Hansen, B. Torok-Storb, D. Dumam, D. Przepiorka, J. O’Quigley, J. Sanders, K.M. Sullivan, R.P. Witherspoon, H.J. Deeg, F.R. Appelbaum, P. Stewart, P. Weiden, K. Doney, C.D. Buckner, R. Clift, R. Storb, and E.D. Thomas. 1988. Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants. Bone Marrow Transplant. 3:445.
4. Keman, N.A., C. Bordignon, G. Heller, I. Cunningham, H. Castro-Malaspina, B. Shank, N. Flomenberg, J. Bums, S.Y. Yang, P. Black, N.H. Collins, and R. O’Reilly. 1989. Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: I. Analysis of risk factors and results of secondary transplants. Blood. 74:2227.
5. Butturini, A., R.C. Seger, and R.P. Gale. 1986. Recipient immune-competent T-lymphocytes can survive intensive conditioning for bone marrow transplantation. Blood. 68:954.
6. Bretagne, S., M. Vidaud, M. Kuentz, C. Cordonnier, T. Henni, G. Vinci, M. Goosens, and J.P. Vemant. 1987. Mixed blood chimerism in T cell-depleted bone marrow transplant recipients: evaluation using DNA polymorphisms. Blood. 70:1692.
7. Bertheas, M.F., D. Maraninchi, M. Lafage, J. Fraisse, D. Blaise, A.M. Stoppa, G. Michel, C.P. Brizard, M.H. Gaspard, G. Novakovitch, P. Mannoni, P. Viens, and Y. Carcassone. 1988. Partial chimerism after T-cell depleted allogeneic bone marrow transplantation in leukemic HLA-matched patients: a cytogenetic documentation. Blood. 72:89.
8. Schouten, H.C., W. Sizoo, M.B. Van’t Veer, A. Hagenbeek, and B. Lowenberg. 1988. Incomplete chimerism in erythroid, myeloid and B lymphocyte lineage after T cell-depieted allogeneic bone marrow transplantation. Bone Marrow Transplant. 3:407.
9. Roy, D.C., R. Tantravahi, C. Murray, K. Dear, B. Gorgone, K.C. Anderson, A.S. Freedman, L.M. Nadler, and J. Ritz. 1990. Natural history of mixed chimerism after bone marrow transplantation with CD6-depleted allogeneic marrow: a stable equilibrium. Blood. 75:296.
10. Offit, K., J.P. Bums, I. Cunningham, S.C. Jhanwar, P. Black, N.A. Kernan, R.J. O’Reilly, and Chaganti, R.S. 1990. Cytogenetic analysis of chimerism and leukemia relapse in chronic myelogenous leukemia patients after T cell-depleted bone marrow transplantation. Blood. 75:1346.
11. Sondel, P.M., J.A. Hank, M.E. Trigg, P.C. Kohler, J.L. Finlay, J. Blank, L. Meisner, W. Borcherding, R. Hong, R. Steves, R. Billing, B. Flynn, and M.J. Bozdech. 1986. Transplantation of HLA-haploidentical T cell-depleted marrow for leukemia: autologous marrow recovery with specific immune sensitization to donor antigens. Exp Hematol. (NY). 14:278.
12. Bunjes, D., W. Heit, R. Arnold, T. Schmeiser, M. Weisneth, R. Carboneil, R. Porzsolt, A. Raghauacher, and H. Heimpel. 1987. Evidence for the involvement of host-derived OKT8-positive T cells in the rejection of T-depleted, HLA-identical bone marrow grafts. Transplantation (Baltimore). 43:501.
13. Keman, N.A., N. Flomenberg, B. Dupont, and R.J. O’Reilly. 1987. Graft rejection in recipients of T-cell depleted HLA-nonidentical marrow transplants for leukemia. Transplantation (Baltimore). 43:842.
14. Sandell, L., G. Johnson, D. Przepiorka, and B. Torok-Storb. 1988. Phenotype and function of T-cells associated with marrow graft failure and rejection. In T-Cell Depletion in Allogeneic Bone-Marrow Transplantation. M.F. Martelli, Grignani, and Y. Reisner, editors. Ares-Serono Symposia, Rome, Italy, 49-56.
15. Bierer, B.E., S.G. Emerson, J. Antin, R. Maziarz, J.M. Rappeport, B.R. Smith, and S.K. Burakoff. 1988. Regulation of cytotoxic T lymphocyte-mediated graft rejection following bone marrow transplantation. Transplantation (Baltimore). 46:835.
16. Bosserman, L.D., C. Murray, T. Takvorian, K.C. Anderson, A.S. Freedman, J. Fitzsimmons, F. Coral, L.M. Nadler, S.F. Schlossman, and J. Ritz. 1989. Mechanism of graft failure in HLA-matched and HLA-mismatched bone marrow transplant recipients. Bone Marrow Transplant. 4:239.
17. Bordignon, C., C.A. Keever, T.N. Small, N. Flomenberg, B. Dupont, R.J. O’Reilly, and N.A. Keman. 1989. Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia. II. In vitro analyses of host effector mechanisms. Blood. 74:2237.
18. Patterson, J., H.G. Prentice, M.K. Brenner, M. Gilmore, G. Janossy, K. Ivory, D. Skeggs, H. Morgan, J. Lord, H.A. Blacklock, A.V. Hofibrand, J.F. Apperley, J.M. Goldman, A. Burnett, J. Bribben, M. Alcorn, C. Pearson, I. McVickers, I.M. Hann, C. Reid, D. Wardle, P.J. Gravett, A. Bacigalupo, and A.G. Robertson. 1986. Graft rejection following HLA matched T-lymphocyte depleted bone marrow transplantation. Br. J. Haematol, 63:221.
19. Guyotat, D., L. Dutou, A. Erhsam, L. Campos, E. Archim-baud, and D. Fiere. 1987. Graft rejection after T cell-depleted marrow transplantation: role of fractionated irradiation. Br. J. Haematol. 65:499.
20. Burnett, A.K., I.M. Hann, A.G. Robertson, M. Alcom, B. Gibson, I. McVicar, L. Niven, S. Mackinnon, H. Hambley, A. Morrison, and A. Todd. 1988. Prevention of graft-versus-host disease ly ex vivo T cell depletion: reduction in graft failure with augmented total body irradiation. Leukemia (Baltimore). 2:300.
21. Ledbetter, J.A., and L.A. Herzenberg. 1979. Xenogenic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol. Rev. 47:63.
22. Wilde, D.B., P. Marrack, J. Kappler, D.P. Dialynas, and F.W. Fitch. 1983. Evidence implicating L3T4 in class II MHC antigen reactivity: monoclonal antibody GK1.5 (anti-L3T4a) blocks class II MHC antigen-specific proliferation, release of lymphokines, and binding ty cloned murine helper T lymphocyte lines. J. Immunol. 131:2178.
23. Sarmiento, M., A.L. Glasebrook, and F.W. Fitch. 1980. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing LYT2 antigen block T cell-mediated cytolysis in the absence of complement. J. Immunol. 125:2665.
24. + helper T cells. J. Exp Med. 171:1315.
25. Leo, O., M. Foo, D.H. Sachs, L.E. Samelson, and J.A. Bluestone. 1987. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA. 84:1374.
26. Ozato, K., N. Mayer, and D.H. Sachs. 1982. Monoclonal antibodies to mouse major histocompatibility complex antigens. Transplantation (Baltimore). 34:113.
27. Ozato, K., N. Mayer, and D.H. Sachs. 1980. Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and la antigens. J. Immunol. 124:533.
28. Shen, F.W. 1981. Monoclonal antibodies to mouse lymphocyte differentiation antigens. In Monoclonal Antibodies and T Cell Hybridomas: Perspectives and Technical Advances. G.J. Hammerling, U. Hämmerling, andJ.F. Kearney, editors. Elsevier Science Publishers B.V. Amsterdam. 25-31.
29. Morse, H.C., F.-W. Shen, and U. Hämmerling. 1987. Genetic nomenclature for loci controlling mouse lymphocyte antigens. Immunogenetics. 25:71.
30. Schwartz, E., T. Lapidot, D. Gozes, T.S. Singer, and Y. Reisner. 1987. Abrogation of bone marrow allograft resistance in mice by increased total body irradiation correlates with eradication of host clonable T-cells and alloreactive cytotoxic precursors. J. Immunol. 138:460.
31. Blazar, B.R., R. Hirsch, R.E. Gress, S.F. Carroll, and D.A. Vallera. 1991. In vivo administration of anti-CD3 monoclonal antibodies or immunotoxins in murine recipients of allogeneic T cell-depleted marrow for the promotion of engraftment. J. Immunol. 147:1492.
32. Hiruma, K., R. Hirsch, M. Patchen, J.A. Bluestone, and R.E. Gress. 1992. Effects of anti-CD3 monoclonal antibody on engraftment of T-cell-depleted bone marrow allografts in mice: host T-cell suppression, growth factors, and space. Blood. 79:3050.
33. Dennert, D., C.G. Anderson, and J. Warner. 1985. T killer cells play a role in allogeneic bone marrow graft rejection but not in hybrid resistance. J. Immunol. 135:3729.
34. Murphy, W.J., V. Kumar, and M. Bennett. 1987. Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized. J. Exp Med. 166:1499.
35. Nakamura, H., and R.E. Gress. 1990. Graft rejection by cytolytic T cells. Transplantation (Baltimore). 49:453.
36. Cobbold, S.P., G. Martin, S. Qin, and H. Waldmann. 1986. Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance. Nature (Lond.). 323:164.
37. Donohue, J., and N.A. Kernan. 1991. Characterization of cells emerging at the time of graft failure following BMT from an unrelated marrow donor. Blood. 78:402a. (Abstr.)
38. Nakamura, N., Y. Kusunoki, and M. Akiyama. 1990. Radiosensitivity of CD4 or CD8 positive human T-lymphocytes by an in vitro colony formation assay. Radiat. Res. 123:224.
39. McCarthy, S.A., and A. Singer. 1986. Recognition of MHC class I allodeterminants regulates the generation of MHC class II-specific CTL. J. Immunol. 137:3087.
40. Murphy, W.J., V. Kumar, J.C. Cope, and M. Bennett. 1990. An absence of T cells in murine bone marrow allografts leads to an increased susceptibility to rejection by natural killer cells and T cells. J. Immunol. 144:3305.
41. Lapidot, T., I. Lubin, A. Terenzi, Y. Faktorowich, P. Erlich, and Y. Reisner. 1990. Enhancement of bone marrow allografts from nude mice into mismatched recipients by T cells void of graft-versus-host activity. Proc Natl. Acad. Sci. USA. 87:4595.
42. Golding, H., T. Mizuochi, S.A. McCarthy, C.A. Cleveland, and A. Singer. 1987. Relationship among function, phenotype, and specificity in primary allospecific T cell populations: identification of phenotypically identical but functionally distinct primary T cell subsets that differ in their recognition of MHC class I and class II allodeterminants. J. Immunol. 138:10.
43. Widmer, M.B., and F.H. Bach. 1981. Antigen driven helper cell independent cloned cytotoxic T lymphocytes. Nature (Lond.). 294:750.
44. Klein, J. 1986. Natural History of the Major Histocompatibility Complex. Wiley-Liss, Inc., New York.
45. Nakamura, H., and R.E. Gress. 1990. Interleukin 2 enhancement of veto suppressor cell function in T-cell-depleted bone marrow in vitro and in vivo. Transplantation (Baltimore). 49:931.
46. + thymocytes. Blood. 80:2406.
47. Lapidot, T., A. Terenzi, T.S. Singer, O. Salomon, and Y. Reisner. 1989. Enhancement by dimethylmyleran of donor type chimerism in murine recipients of bone marrow allografts. Blood. 73:2025.
48. Fu, S.M., N. Chiorazzi, C.Y. Wang, G. Montazeri, H.G. Kunkel, H.S. Ko, and A.B. Gottlieb. 1978. Ia-bearing T lymphocytes in man. Their identification and role in the generation of allogeneic helper activity. J. Exp Med. 148:1423.
49. + T lymphocytes for prevention of graft-versus-host disease after allogeneic bone marrow transplantation. Blood. 76:418.